How Do Bioventures Thrive In APAC? Strategies And Risks Beyond Borders

Japan-Korea Collabs 'Ideal'?

 
• By Lisa Takagi

With the global market in sight, several Asian bioventures discussed at BioJapan event recent projects, strategies and challenges in expanding their businesses in APAC. The different characteristics of policies by country and facets of venture capital funding were some of the topics when speakers talked about “what's the ideal collaboration between Asian bioventures?”

Five speakers talked about challenges and advantages for Asian bioventures
Five speakers talked about challenges and opportunities for Asian bioventures • Source: Lisa Takagi

The challenges and opportunities of running a bioventure depend on which country you’re based in and which market you’re focused on. And it matters too for large pharmaceutical firms in search for the next novel R&D seeds across the APAC region.

At the recent BioJapan 2022 event, five speakers from bioventures and large pharma firms in South Korea, Japan and Taiwan joined a panel discussion to talk about their views of each market. One key thread was that large US opportunities had largely provide the motivation to develop new modalities

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Focus On Asia